Cardio-oncology & other

External validation of the systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in cancer patients

Eur J Prev CardiolPublished External validation study of risk prediction models

Authors' conclusion

SCORE2 underestimated CVD risk in cancer patients.

Study context

Population
Cancer patients from the HUNT3 study (2006–08) diagnosed with cancer within 4 years after enrolment, followed until 2023HUNT3 study
Participants
1,622 patients
Comparison
SCORE2 vs SCORE2-OP
Outcome
Composite of:
  • MI
  • Stroke
  • CVD mortality (10-year fatal and non-fatal CVD risk)
Methodological detailscohort, recalibration by multiplicative adjustment factor based on E/O ratios
  • Cohort
  • Recalibration by multiplicative adjustment factor based on E/O ratios

Performance

As reported in the abstract

Discrimination (Harrel's C-statistic) and calibration
Test or modelC-statisticC-statistic excluding those not surviving first 2 yearsE/O ratio, men (before recalibration)E/O ratio, women (before recalibration)
SCORE20.693 (95% CI 0.643-0.743)0.730 (95% CI 0.676-0.784)0.910.63
SCORE2-OP0.586 (95% CI 0.529-0.643)0.648 (95% CI 0.577-0.720)Not reported in the abstractNot reported in the abstract

C-statistic

SCORE20.693 (95% CI 0.643-0.743)
SCORE2-OP0.586 (95% CI 0.529-0.643)

C-statistic excluding those not surviving first 2 years

SCORE20.730 (95% CI 0.676-0.784)
SCORE2-OP0.648 (95% CI 0.577-0.720)

E/O ratio, men (before recalibration)

SCORE20.91
SCORE2-OPNot reported in the abstract

E/O ratio, women (before recalibration)

SCORE20.63
SCORE2-OPNot reported in the abstract

Further findings

Cardiovascular disease (CVD) events and non-CVD deaths · median follow-up 8.8 years [IQR 1.9-12.6]

CVD events (39% myocardial infarction (MI), 36% stroke, 25% CVD deaths)
252
Non-CVD deaths
708

Original publication

External validation of the systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in cancer patients. Eur J Prev Cardiol. Published 23 June 2025. doi:10.1093/eurjpc/zwaf356

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.